Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–13 of 13 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Searching for clinical trials...
NCT03990428
- Conditions
- Erdheim-Chester Disease, Hemic and Lymphatic Diseases, Histiocytosis, +3 more
- Locations
-
- Memorial Sloan Kettering Cancer Center New York, United States
Recruiting
Histiocytic Disorder Follow-up Study
NCT05915208
- Conditions
- Erdheim-Chester Disease, Hemic and Lymphatic Diseases, Histiocytic Disorders, Malignant, +16 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
NCT07454343
- Conditions
- Erdheim-Chester Disease, Erdheim-Chester Disease (ECD), Hemic and Lymphatic Diseases, +3 more
- Locations
-
- National Institute of Health Bethesda, Maryland, United States
- Mayo Clinic Rochester, Minnesota, United States
- Memorial Sloan Kettering Cancer Center New York, United States
- Hopital Pitiè-Salpetriere Paris, France
NCT05093335
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Erdheim-Chester Disease, +22 more
- Locations
-
- Memorial Sloan Kettering Cancer Center New York, United States
NCT03329274
- Conditions
- Erdheim-Chester Disease, Hemic and Lymphatic Diseases, Histiocytosis, +7 more
- Locations
-
- Memorial Sloan Kettering Cancer Center New York, United States
NCT05768178
- Conditions
- Adenocarcinoma, Adenocarcinoma, Papillary, Adnexal Diseases, +74 more
- Locations
-
- Belfast City Hospital Belfast, United Kingdom
- University Hospital Birmingham Birmingham, United Kingdom
- Bristol Haematology and Oncology Centre Bristol, United Kingdom
- Addenbrooke's Hospital Cambridge, United Kingdom
NCT06712810
- Conditions
- Blastic Plasmacytoid Dendritic Cell Neoplasm, Blood Protein Disorders, Bone Marrow Diseases, +87 more
- Locations
-
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- Mayo Clinic in Rochester Rochester, Minnesota, United States
Recruiting
Cobimetinib in Refractory Langerhans Cell Histiocytosis (LCH), and Other Histiocytic Disorders
NCT04079179
- Conditions
- Erdheim-Chester Disease, Hemic and Lymphatic Diseases, Histiocytic Disorders, Malignant, +18 more
- Locations
-
- Phoenix Children's Hospital Phoenix, Arizona, United States
- Arkansas Children's Hospital Little Rock, Arkansas, United States
- Children's Hospital of Orange County Orange, California, United States
- UCSF Benioff Children's Hospital San Francisco, California, United States
NCT02285582
- Conditions
- ALK-positive Histiocytosis, Collagen Diseases, Connective Tissue Diseases, +27 more
- Locations
-
- The University of Alabama at Birmingham Birmingham, Alabama, United States
- Children's Hospital of Los Angeles Los Angeles, California, United States
- Valley Children's Hospital Madera, California, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
Not Yet Recruiting
DETERMINE Trial Treatment Arm 07: Dabrafenib in Combination With Trametinib in Adult, Paediatric and Teenage/Young Adult Patients With BRAF V600 Mutation-Positive Cancers.
NCT07440290
- Conditions
- Adenocarcinoma, Adenocarcinoma, Papillary, Adnexal Diseases, +77 more
- Locations
-
- Belfast City Hospital Belfast, United Kingdom
- University Hospital Birmingham Birmingham, United Kingdom
- Birmingham Children's Hospital Birmingham, United Kingdom
- Bristol Royal Hospital for Children Bristol, United Kingdom
NCT01417520
- Conditions
- Albinism, Albinism, Oculocutaneous, Amino Acid Metabolism, Inborn Errors, +50 more
- Locations
-
- National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
NCT02608619
- Conditions
- Erdheim-Chester Disease, Hemic and Lymphatic Diseases, Histiocytic Disorders, +8 more
- Locations
-
- Memoral Sloan Kettering Cancer Center New York, United States
Active, Not Recruiting
Lenalidomide for Adult Histiocyte Disorders
NCT02523040
- Conditions
- Erdheim-Chester Disease, Hemic and Lymphatic Diseases, Histiocytic Disorders, Malignant, +13 more
- Locations
-
- Dana-Farber Cancer Institute Boston, Massachusetts, United States